Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Product
1.4.2 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Application
1.4.3 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by End User
1.4.4 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Technology
1.4.5 LAMEA Non-invasive Prenatal Testing (NIPT) Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product
4.1 LAMEA Consumables & Reagents Market by Country
4.2 LAMEA Instruments Market by Country
Chapter 5. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application
5.1 LAMEA Trisomy Market by Country
5.2 LAMEA Microdeletion Syndrome Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User
6.1 LAMEA Diagnostic Laboratories Market by Country
6.2 LAMEA Hospitals & Clinics Market by Country
Chapter 7. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology
7.1 LAMEA Next Generation Sequencing (NGS) Market by Country
7.2 LAMEA Microarray Market by Country
7.3 LAMEA Polymerase Chain Reaction (PCR) Market by Country
7.4 LAMEA Rolling Circular Amplification Market by Country
Chapter 8. LAMEA Non-invasive Prenatal Testing (NIPT) Market by Country
8.1 Brazil Non-invasive Prenatal Testing (NIPT) Market
8.1.1 Brazil Non-invasive Prenatal Testing (NIPT) Market by Product
8.1.2 Brazil Non-invasive Prenatal Testing (NIPT) Market by Application
8.1.3 Brazil Non-invasive Prenatal Testing (NIPT) Market by End User
8.1.4 Brazil Non-invasive Prenatal Testing (NIPT) Market by Technology
8.2 Argentina Non-invasive Prenatal Testing (NIPT) Market
8.2.1 Argentina Non-invasive Prenatal Testing (NIPT) Market by Product
8.2.2 Argentina Non-invasive Prenatal Testing (NIPT) Market by Application
8.2.3 Argentina Non-invasive Prenatal Testing (NIPT) Market by End User
8.2.4 Argentina Non-invasive Prenatal Testing (NIPT) Market by Technology
8.3 UAE Non-invasive Prenatal Testing (NIPT) Market
8.3.1 UAE Non-invasive Prenatal Testing (NIPT) Market by Product
8.3.2 UAE Non-invasive Prenatal Testing (NIPT) Market by Application
8.3.3 UAE Non-invasive Prenatal Testing (NIPT) Market by End User
8.3.4 UAE Non-invasive Prenatal Testing (NIPT) Market by Technology
8.4 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market
8.4.1 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Product
8.4.2 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Application
8.4.3 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by End User
8.4.4 Saudi Arabia Non-invasive Prenatal Testing (NIPT) Market by Technology
8.5 South Africa Non-invasive Prenatal Testing (NIPT) Market
8.5.1 South Africa Non-invasive Prenatal Testing (NIPT) Market by Product
8.5.2 South Africa Non-invasive Prenatal Testing (NIPT) Market by Application
8.5.3 South Africa Non-invasive Prenatal Testing (NIPT) Market by End User
8.5.4 South Africa Non-invasive Prenatal Testing (NIPT) Market by Technology
8.6 Nigeria Non-invasive Prenatal Testing (NIPT) Market
8.6.1 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Product
8.6.2 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Application
8.6.3 Nigeria Non-invasive Prenatal Testing (NIPT) Market by End User
8.6.4 Nigeria Non-invasive Prenatal Testing (NIPT) Market by Technology
8.7 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market
8.7.1 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Product
8.7.2 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Application
8.7.3 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by End User
8.7.4 Rest of LAMEA Non-invasive Prenatal Testing (NIPT) Market by Technology
Chapter 9. Company Profiles
9.1 Illumina, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Natera Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 PerkinElmer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 Laboratory Corporation of America Holdings
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 SWOT Analysis
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Product Launches and Product Expansions:
9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 WOT Analysis
9.8 GE HealthCare Technologies, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Pacific Biosciences of California, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Unique Offerings 